TOI
insider transactionsOncology Institute, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-6.2M
626.4K buy · 6.8M sell
Net value · 365d
-$19.1M
$1.9M in · $21.0M out
Sentiment · 365d
Net selling
8% buying · 92% selling
Open-market trades · 365d
15
626.4K buy · 6.8M sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Buy·P
TenPercentOwner
$81.2K
27.4K sh · $2.96
Own +0%
-
Buy·P
TenPercentOwner
$157.5K
50.0K sh · $3.15
Own +0%
-
Buy·P
TenPercentOwner
$388.8K
125.0K sh · $3.11
Own +1%
-
Buy·P
TenPercentOwner
$83.8K
25.0K sh · $3.35
Own +0%
-
Buy·P
TenPercentOwner
$256.5K
75.0K sh · $3.42
Own +1%
-
Other·J
Chief Financial Officer
$4.7K
1.3K sh · $3.59
-
Other·J
Chief Medical Officer
$12.3K
3.4K sh · $3.59
-
Other·J
Virnich Daniel KEY
Chief Executive Officer
$42.5K
11.8K sh · $3.59
-
Buy·P
TenPercentOwner
$200.6K
61.0K sh · $3.29
Own +1%
-
Buy·P
TenPercentOwner
$768.0K
263.0K sh · $2.92
Own +3%
-
Sell·S
Chief Financial Officer
$879
247 sh · $3.56
Own -0%
-
Other·J
Chief Financial Officer
$895
244 sh · $3.67
-
Sell·S
Director
$50.3K
13.3K sh · $3.77
Own -2%
-
Grant·A
Director
$0
40.1K sh
Own +16%
-
Grant·A
Director
$0
67.9K sh
Own +37%
-
Grant·A
Director
$0
46.3K sh
Own +19%
-
Grant·A
Director
$0
37.0K sh
Own +12%
-
Grant·A
Director
$0
41.7K sh
Own +7%
-
Grant·A
Director
$0
32.4K sh
Own +5%
-
Grant·A
Director
$0
47.8K sh
Own +24%
-
Grant·A
Director
$0
37.0K sh
Own +15%
-
Grant·A
Director
$0
46.3K sh
Own +26%
-
Grant·A
Director
$0
35.5K sh
Own +16%
-
Grant·A
Director
$0
50.9K sh
Own +29%
-
Grant·A
Director
$0
40.1K sh
Own +18%
-
Sell·S
Director
$4.8K
1.2K sh · $4.00
Own -1%
-
Sell·S
Director
$8.6K
2.2K sh · $4.00
Own -1%
-
Sell·S
Director
$186.5K
46.6K sh · $4.00
Own -21%
-
Other·J
Director
—
11.8K sh
-
Other·J
Director
—
590.9K sh
-
Other·J
Director
—
2.5M sh
-
Other·J
Director
—
141.1K sh
-
Grant·A
Virnich Daniel KEY
Chief Executive Officer
$0
6.5K sh
Own +0%
-
Grant·A
Chief Financial Officer
$0
195 sh
Own +0%
-
Grant·A
Chief Medical Officer
$0
2.1K sh
Own +1%
-
Grant·A
Virnich Daniel KEY
Chief Executive Officer
$0
6.2K sh
Own +0%
-
Grant·A
Chief Medical Officer
$0
1.2K sh
Own +1%
-
Grant·A
Chief Medical Officer
$0
306 sh
Own +0%
-
Sell·S
Director,TenPercentOwner
$18.6M
6.0M sh · $3.09
Own -43%
-
Sell·S
Director,TenPercentOwner
$2.1M
681.8K sh · $3.09
Own -54%
-
Sell·S
Director
$82.1K
20.2K sh · $4.06
Own -3%
-
Other·J
Director
$0
287.8K sh
-
Grant·A
Chief Administrative Officer
$0
98.0K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Mar 27, 2026 | Chernett Jorey | Buy P | 27.4K | $81.2K |
| Mar 26, 2026 | Chernett Jorey | Buy P | 50.0K | $157.5K |
| Mar 24, 2026 | Chernett Jorey | Buy P | 125.0K | $388.8K |
| Mar 20, 2026 | Chernett Jorey | Buy P | 25.0K | $83.8K |
| Mar 17, 2026 | Chernett Jorey | Buy P | 75.0K | $256.5K |
| Mar 17, 2026 | Carter Robert Ross KEY | Other J | 1.3K | $4.7K |
| Mar 17, 2026 | Podnos Yale | Other J | 3.4K | $12.3K |
| Mar 17, 2026 | Virnich Daniel KEY | Other J | 11.8K | $42.5K |
| Mar 16, 2026 | Chernett Jorey | Buy P | 61.0K | $200.6K |
| Mar 13, 2026 | Chernett Jorey | Buy P | 263.0K | $768.0K |
| Jan 2, 2026 | Carter Robert Ross KEY | Sell S | 247 | $879 |
| Jan 2, 2026 | Carter Robert Ross KEY | Other J | 244 | $895 |
| Dec 15, 2025 | Hively Brad | Sell S | 13.3K | $50.3K |
| Nov 20, 2025 | McGeorge Anne | Grant A | 40.1K | $0 |
| Nov 20, 2025 | McGeorge Anne | Grant A | 67.9K | $0 |
| Nov 20, 2025 | Ling Gabriel | Grant A | 46.3K | $0 |
| Nov 20, 2025 | Ling Gabriel | Grant A | 37.0K | $0 |
| Nov 20, 2025 | Hively Brad | Grant A | 41.7K | $0 |
| Nov 20, 2025 | Hively Brad | Grant A | 32.4K | $0 |
| Nov 20, 2025 | Johnson Karen Marie | Grant A | 47.8K | $0 |
| Nov 20, 2025 | Johnson Karen Marie | Grant A | 37.0K | $0 |
| Nov 20, 2025 | Pacala Mark L | Grant A | 46.3K | $0 |
| Nov 20, 2025 | Pacala Mark L | Grant A | 35.5K | $0 |
| Nov 20, 2025 | Kaushal Mohit | Grant A | 50.9K | $0 |
| Nov 20, 2025 | Kaushal Mohit | Grant A | 40.1K | $0 |
| Nov 18, 2025 | Pacala Mark L | Sell S | 1.2K | $4.8K |
| Nov 18, 2025 | Pacala Mark L | Sell S | 2.2K | $8.6K |
| Nov 18, 2025 | Pacala Mark L | Sell S | 46.6K | $186.5K |
| Nov 18, 2025 | TOI M, LLC | Other J | 11.8K | — |
| Nov 18, 2025 | TOI M, LLC | Other J | 590.9K | — |
| Nov 18, 2025 | TOI M, LLC | Other J | 2.5M | — |
| Nov 18, 2025 | Ling Gabriel | Other J | 141.1K | — |
| Nov 17, 2025 | Virnich Daniel KEY | Grant A | 6.5K | $0 |
| Nov 17, 2025 | Carter Robert Ross KEY | Grant A | 195 | $0 |
| Nov 17, 2025 | Podnos Yale | Grant A | 2.1K | $0 |
| Nov 12, 2025 | Virnich Daniel KEY | Grant A | 6.2K | $0 |
| Nov 12, 2025 | Podnos Yale | Grant A | 1.2K | $0 |
| Nov 12, 2025 | Podnos Yale | Grant A | 306 | $0 |
| Sep 4, 2025 | M33 Growth I GP LLC | Sell S | 6.0M | $18.6M |
| Sep 4, 2025 | M33 Growth I GP LLC | Sell S | 681.8K | $2.1M |
| Aug 19, 2025 | Hively Brad | Sell S | 20.2K | $82.1K |
| Jul 24, 2025 | BARASCH RICHARD A | Other J | 287.8K | $0 |
| Jul 22, 2025 | England Kristin | Grant A | 98.0K | $0 |
About TOI insider trading
This page tracks insider transactions for Oncology Institute, Inc. (TOI) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.